Seegene Inc

Select Menu

Press Release You can check out news about Seegene from various media

Dec. 05
2025
N

Seegene Establishes French Subsidiary to Expand European Footprint

• France becomes Seegene’s eighth overseas sales subsidiary and third in Europe, following Italy and Germany• The country ranks as Europe’s second-largest molecular diagnostics market, driven by deman...
Sep. 02
2025

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

• The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026 • Selected resea...
Aug. 06
2025

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics

• Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testing • Introduction of CURECA™, the first fully unattended PCR automatio...
Jul. 04
2025

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

• Real-time analytics that empower clinical decision-making and pandemic preparedness • Global unveiling at ADLM 2025 in Chicago to initiate business partnerships • Powe...
May. 08
2025

Seegene’s CURECA™ Emerges as a Potential Game Changer in End-to-End PCR Automation

• Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July • With a fully modular design, CURECATM introduces a bold vision for automating pre-...
Apr. 09
2025

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation

• Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025—a full automation system expected to cover the entire PCR workforce, from sample pre-processing to result analysis.• ...
Mar. 20
2025

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025

· Presented a roadmap to enhance screening reliability at the world’s leading multidisciplinary HPV congress held in Portugal from March 16-19· Demonstrated how self-collected samples for HPV testing ...
Oct. 24
2024

Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative

• The first tri-party executive roundtable was held in London to strengthen synergies for Seegene’s vision of creating ‘a world free from diseases’ • Preliminary results of product deve...
Oct. 08
2024

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

- Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene’s technology-sharing initiative- The two companies wil...
Sep. 10
2024

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

- Introduces NovaplexTM MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II- ...
Sep. 02
2024

Seegene and Springer Nature Launch ‘Nature Awards MDx Impact Grants’ to Innovate Syndromic PCR Diagnostic Assays

- Nature Awards MDx Impact Grants in partnership with Seegene extends commitment to external innovation.- Global research teams invited to submit proposals to develop new tests for human infectious di...
Aug. 27
2024

Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration

- Develops Novaplex™ MPXV/OPXV Assay and Novaplex™ HSV-1&2/VZV/MPXV Assay- Designed to detect four viruses at once using multiplex PCR technology- Utilize dual internal controls to ensur...
Aug. 05
2024

Seegene Showcased Its Multiplex Technology at ADLM 2024

- Exhibited multiplex PCR testing technologies that provide comprehensive results from a single test - Presented high-multiplex assays and automated testing systems - Introduced the SG OneSystem™ bu...
Jul. 16
2024

Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024

- Showcases AllplexTM HPV products designed to test for 14 high-risk HPV genotypes - Advocates HPV testing for early diagnosis and prevention of cervical cancer - Aims to ...

1 2 3 4 5

Choose your country

Press Release You can check out news about Seegene from various media

Seegene Establishes French Subsidiary to Expand European Footprint

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

Seegene’s CURECA™ Emerges as a Potential Game Changer in End-to-End PCR Automation

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025

Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

Seegene and Springer Nature Launch ‘Nature Awards MDx Impact Grants’ to Innovate Syndromic PCR Diagnostic Assays

Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration

Seegene Showcased Its Multiplex Technology at ADLM 2024

Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024